Fig. 1: Study overview.
From: Genetic determinants and genomic consequences of non-leukemogenic somatic point mutations
Schematic, describing the development of GEM (top panel), the use of GEM to discover the genetic determinants of mutation burden in blood (middle panel), and the use of GEM to identify the transcriptomic and clinical correlates of mutation burden in blood (bottom panel).
